Q4 2022 Holdings
Filed 2023-01-31 | 391 holdings | $248.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-05-22) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Novavax Inc(NVAX)A | Common Stock | 670002401 | $8.8K | 854 | 0.0% |
| Lyell Immunopharma IncA | Common Stock | 55083R104 | $8.8K | 2,533 | 0.0% |
| Veeva Systems Inc(VEEV)A | Common Stock | 922475108 | $8.9K | 55 | 0.0% |
| Ideaya Biosciences Inc(IDYA)A | Common Stock | 45166A102 | $8.9K | 489 | 0.0% |
| Anaptysbio Inc(ANAB)A | Common Stock | 032724106 | $9.0K | 289 | 0.0% |
| Arcutis Biotherapeutics Inc(ARQT)A | Common Stock | 03969K108 | $9.2K | 619 | 0.0% |
| Allogene Therapeutics Inc(ALLO)A | Common Stock | 019770106 | $9.2K | 1,465 | 0.0% |
| Provention BIO Inc(PRVBUSD)A | Common Stock | 74374N102 | $9.4K | 886 | 0.0% |
| Geron Corp(GERN)A | Common Stock | 374163103 | $9.4K | 3,873 | 0.0% |
| Innoviva Inc(INVA)A | Common Stock | 45781M101 | $9.4K | 709 | 0.0% |
| Pliant Therapeutics Inc(PLRX)A | Common Stock | 729139105 | $9.6K | 495 | 0.0% |
| Grifols SA(GRFS)A | ADR | 398438408 | $9.6K | 1,129 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA)A | Common Stock | 29251M106 | $9.8K | 211 | 0.0% |
| Regenxbio Inc(RGNX)A | Common Stock | 75901B107 | $10.0K | 439 | 0.0% |
| Fate Therapeutics Inc(FATE)A | Common Stock | 31189P102 | $10.0K | 987 | 0.0% |
| Crinetics Pharmaceuticals in(CRNX)A | Common Stock | 22663K107 | $10.0K | 547 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA)A | Common Stock | 462260100 | $10.2K | 1,603 | 0.0% |
| Morphic Holding IncA | Common Stock | 61775R105 | $10.5K | 392 | 0.0% |
| Bellus Health Inc(BLU)A | Common Stock | 07987C204 | $10.5K | 1,277 | 0.0% |
| Aclaris Therapeutics Inc(ACRS)A | Common Stock | 00461U105 | $10.7K | 678 | 0.0% |
| Inhibrx Inc(INBXUSD)A | Common Stock | 45720L107 | $10.9K | 442 | 0.0% |
| Adaptive Biotechnologies(ADPT)A | Common Stock | 00650F109 | $11.1K | 1,453 | 0.0% |
| Immunogen Inc(IMGNEUR)A | Common Stock | 45253H101 | $11.1K | 2,242 | 0.0% |
| Jd.com Inc(JD)A | ADR | 47215P106 | $11.2K | 200 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR)A | Common Stock | 24344T101 | $11.3K | 687 | 0.0% |
| Ligand Pharmaceuticals(LGND)A | Common Stock | 53220K504 | $11.4K | 171 | 0.0% |
| Bridgebio Pharma Inc(BBIO)A | Common Stock | 10806X102 | $11.6K | 1,519 | 0.0% |
| Curevac NVA | Common Stock | N2451R105 | $11.7K | 1,933 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL)A | Common Stock | 98943L107 | $11.7K | 579 | 0.0% |
| Myriad Genetics Inc(MYGN)A | Common Stock | 62855J104 | $11.9K | 823 | 0.0% |
| Verve Therapeutics IncA | Common Stock | 92539P101 | $12.1K | 626 | 0.0% |
| Eqrx IncA | Common Stock | 26886C107 | $12.2K | 4,962 | 0.0% |
| Avidity Biosciences Inc(RNA)A | Common Stock | 05370A108 | $12.3K | 553 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR)A | Common Stock | 75615P103 | $12.3K | 323 | 0.0% |
| Keros Therapeutics Inc(KROS)A | Common Stock | 492327101 | $13.4K | 280 | 0.0% |
| Twist Bioscience Corp(TWST)A | Common Stock | 90184D100 | $13.7K | 574 | 0.0% |
| Travere Therapeutics Inc(TVTX)A | Common Stock | 89422G107 | $13.7K | 652 | 0.0% |
| Replimune Group Inc(REPL)A | Common Stock | 76029N106 | $13.7K | 505 | 0.0% |
| Amphastar Pharmaceuticals in(AMPH)A | Common Stock | 03209R103 | $13.8K | 491 | 0.0% |
| Arcellx Inc(ACLX)A | Common Stock | 03940C100 | $13.8K | 445 | 0.0% |
| Kymera Therapeutics Inc(KYMR)A | Common Stock | 501575104 | $13.9K | 557 | 0.0% |
| Mannkind Corp(MNKD)A | Common Stock | 56400P706 | $14.1K | 2,674 | 0.0% |
| Recursion Pharmaceuticals(RXRX)A | Common Stock | 75629V104 | $14.2K | 1,846 | 0.0% |
| Immunocore Holdings PLC(IMCR)A | ADR | 45258D105 | $15.0K | 262 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT)A | Common Stock | 77313F106 | $15.0K | 769 | 0.0% |
| Dice Therapeutics IncA | Common Stock | 23345J104 | $15.1K | 484 | 0.0% |
| Fibrogen Inc(FGENEUR)A | Common Stock | 31572Q808 | $15.3K | 955 | 0.0% |
| Nuvalent Inc(NUVL)A | Common Stock | 670703107 | $15.4K | 518 | 0.0% |
| Revance Therapeutics Inc(RVNCEUR)A | Common Stock | 761330109 | $15.4K | 836 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX)A | Common Stock | 87164F105 | $15.6K | 612 | 0.0% |